CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.

December 22, 2022

Seasons Greetings 2022

The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!

October 11, 2022

Strengthening the team

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager

September 20, 2022

Good press in SvD

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Pain

Pain

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

David Finn

Andrew Russo

Zsuzsanna Helyes

Eamon Kelly

Latest news

PharmNovo at Biostock

Seasons Greetings 2022

Strengthening the team

Good press in SvD